Density of GFAP-immunoreactive astrocytes is decreased in left hippocampi in major depressive disorder.
Density of GFAP-immunoreactive astrocytes is decreased in left hippocampi in major depressive disorder.
复制标题
DOI：
10.1016/j.neuroscience.2015.12.044
复制
发表时间：
2016-03-01
期刊：
影响因子：
3.3
通讯作者：
Stockmeier CA
中科院分区：
文献类型：
--
作者：
Cobb JA;O'Neill K;Milner J;Mahajan GJ;Lawrence TJ;May WL;Miguel-Hidalgo J;Rajkowska G;Stockmeier CA
Neuroimaging and postmortem studies of subjects with major depressive disorder (MDD) reveal smaller hippocampal volume with lengthening duration of illness. Pathology in astrocytes may contribute significantly to this reduced volume and to the involvement of the hippocampus in MDD. Postmortem hippocampal tissues were collected from 17 subjects with major depressive disorder and 17 psychiatrically-normal control subjects. Sections from the body of the hippocampus were immunostained for glial fibrillary acidic protein (GFAP), a marker of intermediate filament protein expressed in astrocytes. The density of GFAP-immunoreactive astrocytes was measured in the hippocampus using 3-dimensional cell counting. Hippocampal subfields were also assessed for GFAP-immunoreactive area fraction. In CA1, there was a significant positive correlation between age and either density or area fraction in MDD. The density of astrocytes in the hilus, but not CA1 or CA2/3, was significantly decreased only in depressed subjects not taking an antidepressant drug, but not for depressed subjects taking an antidepressant drug. The area fraction of GFAP-immunoreactivity was significantly decreased in the dentate gyrus in women but not men with depression. In CA2/3, the area fraction of GFAP-immunoreactivity was inversely correlated with the duration of depression in suicide victims. Astrocyte contributions to neuronal function in the hilus may be compromised in depressed subjects not taking antidepressant medication. Due to the cross-sectional nature of the present study of postmortem brain tissue, it remains to be determined whether antidepressant drug treatment prevented a decrease in GFAP-immunoreactive astrocyte density or restored cell density to normal levels.
